RMD
NEUTRAL
$205.02
Live
ResMed Inc. · NYSE
Target $273.4
(+33.4%)
$198.64
52W Range
$293.81
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
85%
ResMed exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet (Debt/Equity 0.13). While the current price of $205.02 sits significantly above the Graham Number ($100.62), it remains a substantial discount to the growth-based Intrinsic Value of $298.14. High profitability metrics, including an ROE of 25.68% and operating margins of 35.16%, are currently offset by severe bearish technical momentum and consistent insider selling. The stock presents a classic conflict between strong fundamental value and negative market sentiment.
Key Strengths
Exceptional balance sheet with very low Debt/Equity (0.13) and high liquidity (Current Ratio 3.06)
Strong profitability with a 27.53% profit margin and 25.68% ROE
Consistent earnings track record with 3 out of the last 4 quarters beating estimates
Healthy revenue and earnings growth (11% and 14.5% YoY respectively)
Significant discount to growth-based intrinsic value ($298.14) and analyst targets ($273.40)
Key Risks
Strongly bearish technical trend (0/100) indicating significant downward momentum
Bearish insider sentiment with 15 sell transactions and zero buys in the last 6 months
Negative price performance across 1-year (-12.5%) and 6-month (-16.6%) timeframes
Price is trading at a significant premium to the defensive Graham Number ($100.62)
Concentration risk within the medical instruments sector
AI Fair Value Estimate
Based on comprehensive analysis
$235.5
+14.9% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare RMD against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning RMD from our newsroom.
Newest → oldest
No matching news yet.